- Home
- AIOT vs CRBP Comparison
AIOT vs CRBP Comparison
Compare AIOT & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIOT
- CRBP
- Stock Information
- Founded
- AIOT 1993
- CRBP 2009
- Country
- AIOT United States
- CRBP United States
- Employees
- AIOT N/A
- CRBP N/A
- Industry
- AIOT Telecommunications Equipment
- CRBP Biotechnology: Pharmaceutical Preparations
- Sector
- AIOT Telecommunications
- CRBP Health Care
- Exchange
- AIOT Nasdaq
- CRBP Nasdaq
- Market Cap
- AIOT 594.8M
- CRBP 96.5M
- IPO Year
- AIOT N/A
- CRBP N/A
- Fundamental
- Price
- AIOT $4.25
- CRBP $8.22
- Analyst Decision
- AIOT Strong Buy
- CRBP Strong Buy
- Analyst Count
- AIOT 4
- CRBP 10
- Target Price
- AIOT $10.50
- CRBP $53.56
- AVG Volume (30 Days)
- AIOT 2.2M
- CRBP 214.0K
- Earning Date
- AIOT 08-07-2025
- CRBP 08-05-2025
- Dividend Yield
- AIOT N/A
- CRBP N/A
- EPS Growth
- AIOT N/A
- CRBP N/A
- EPS
- AIOT N/A
- CRBP N/A
- Revenue
- AIOT $362,515,000.00
- CRBP N/A
- Revenue This Year
- AIOT $21.96
- CRBP N/A
- Revenue Next Year
- AIOT $10.74
- CRBP $150.03
- P/E Ratio
- AIOT N/A
- CRBP N/A
- Revenue Growth
- AIOT 169.28
- CRBP N/A
- 52 Week Low
- AIOT $3.70
- CRBP $4.64
- 52 Week High
- AIOT $8.71
- CRBP $61.90
- Technical
- Relative Strength Index (RSI)
- AIOT 40.41
- CRBP 54.23
- Support Level
- AIOT $4.13
- CRBP $7.26
- Resistance Level
- AIOT $4.52
- CRBP $7.90
- Average True Range (ATR)
- AIOT 0.19
- CRBP 0.53
- MACD
- AIOT 0.01
- CRBP -0.01
- Stochastic Oscillator
- AIOT 18.75
- CRBP 78.59
About AIOT PowerFleet Inc. Common Stock
PowerFleet Inc is engaged in Internet-of-Things (IoT) solutions providing valuable business intelligence for managing high-value enterprise assets that improve operational efficiencies. It provide critical information that powers unified operations throughout organizations. It is solving the challenge of inefficient data collection, real-time visibility, and analysis that leads to transformative business operations. Its SaaS cloud-based applications take data from IoT devices and ecosystem of third-party and partner applications to present actionable information for customer.
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.